Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Jour

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BJU International|March 20, 2022
Urological stone disease: a 5-year update of stone management using Hospital Episode StatisticsIbrahim Jour, Angela Lam, Ben Turney
Le Journal Medical Libanais. the Lebanese Medical Journal|December 4, 2012
Bladder paraganglioma. A case reportFouad El Khoury, Ibrahim Jour, Bassem Malaeb, et al.
Current Urology|November 23, 2020
A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract InfectionsAndrew Brodie, Omar El-Taji, Ibrahim Jour, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BJU International|March 20, 2022
Urological stone disease: a 5-year update of stone management using Hospital Episode StatisticsIbrahim Jour, Angela Lam, Ben Turney
Le Journal Medical Libanais. the Lebanese Medical Journal|December 4, 2012
Bladder paraganglioma. A case reportFouad El Khoury, Ibrahim Jour, Bassem Malaeb, et al.
Current Urology|November 23, 2020
A Retrospective Study of Immunotherapy Treatment with Uro-Vaxom (OM-89®) for Prophylaxis of Recurrent Urinary Tract InfectionsAndrew Brodie, Omar El-Taji, Ibrahim Jour, et al.
Pageof 1